Chart of the Week: SNB Forex Interventions

Macro

Christopher Dembik

Head of Macro Analysis

Summary:  The Swiss National Bank (SNB) is engaged in battle it seems less and less likely to win.


The Swiss National Bank (SNB) is engaged in battle it seems less and less likely to win. Since the beginning of the year, the CHF has lost almost 1.8% versus the EUR and more than 6% over a year. This past Monday, the CHF reached its highest level since July 2015 against the euro as Cov-19 fears spread in financial markets and risk aversion skyrocketed. Judging by hedge funds positioning, the CHF is considered good as gold for many investors in order to curtail the risk linked to coronavirus.

While the SNB has intensified its forex interventions in the market since mid-January, with total sight deposits reaching CHF592.3bn from CHF590.1bn last week, it is getting more and more obvious that it has only been able to limit the appreciation of the CHF and not to stop it. Contrary to what has happened in summer 2019, the situation facing the SNB is much more complicated. Fears are not related to trade war and limited damages to the economy, as it was the case, but to uncertainty resulting from an exogenous factor with global economic implications. What is even more worrying for investors is that, at this stage, no one is able to price to economic and financial cost related to the coronavirus outbreak.

Considering uncertainty will prevail at least for a few more weeks, it is likely that the Swiss franc will continue to rise, pushing the SNB to come more significantly into the market. We believe that the central bank will do all its best to defend the psychological threshold at 1.05 on the EURCHF cross, but a breakdown, that would open the door to further decline, is perfectly conceivable if the coronavirus is not handled fast.

Access to Macrochartmania.

Disclaimer

Saxo Capital Markets (Australia) Pty Ltd prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Combined Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at https://www.home.saxo/en-au/legal/.

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

Please read our disclaimers:
- Full Disclaimer (https://www.home.saxo/en-au/legal/disclaimer/saxo-disclaimer)
- Analysis Disclaimer (https://www.home.saxo/en-au/legal/analysis-disclaimer/saxo-analysis-disclaimer)
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-au/about-us/awards

Saxo Capital Markets (Australia) Pty Ltd ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide and Product Disclosure Statement to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as CFDs and Margin FX products may result in your losses surpassing your initial deposits. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.
Please click here to view our full disclaimer.